Advertisement

Topics

Coherus secures $150mm funding commitment from Temasek; first $75mm tranche received

15:40 EDT 23 Aug 2017 | Elsevier Business Intelligence

Coherus Biosciences Inc. (biosimilars) secured a $150mm funding commitment from Temasek Holdings, which provided an initial $...

Original Article: Coherus secures $150mm funding commitment from Temasek; first $75mm tranche received

NEXT ARTICLE

More From BioPortfolio on "Coherus secures $150mm funding commitment from Temasek; first $75mm tranche received"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...